This inventor holds 2 USPTO granted patents. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2004
Title: Innovations of Johannes Waltenberger
Introduction
Johannes Waltenberger is a notable inventor based in Ulm, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitory compounds. With a total of 2 patents to his name, his work has implications for various therapeutic applications.
Latest Patents
Waltenberger's latest patents include innovative compounds that inhibit PDGF receptor kinase. These patents detail the preparation, purification, and pharmaceutical compositions of these compounds, showcasing his expertise in medicinal chemistry and drug development.
Career Highlights
Waltenberger is associated with the Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His role in this esteemed organization highlights his commitment to advancing research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Waltenberger has collaborated with esteemed colleagues such as Alexander Levitzki and Aviv Gazit. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Johannes Waltenberger's contributions to the field of pharmaceutical sciences through his patents and collaborations underscore his importance as an inventor. His work continues to influence the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile